Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03454568 · ClinicalTrials.gov registry record
The Patients' Experience After Stem Cell Transplant
A clinical trial, sponsored by University of Nebraska.
- Completed
- Registry status
- 110
- Enrollment target
NCT03454568: Completed study, sponsored by University of Nebraska.
NCT03454568 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 110 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03454568 has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 110 participants
- Enrollment target
Study Summary
This study will examine how adults ≥ 60 years old thinking and memory abilities are affected by stem cell transplant; whether these changes affect day-to-day activities and quality of life and how thinking and memory abilities are affected by genetics, depression, anxiety and physical function. Genetics and other factors may affect the brain's chemicals or structure, and may increase risk for negative effects on thinking and memory.
Primary Outcome
Cognition will be measured using a neuropsychological battery.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2017-09-01 |
| Est. Completion | 2022-11-11 |
What the finished NCT03454568 record still lists
NCT03454568 is an observational study that tracks outcomes without assigning an intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03454568 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03454568 about?
NCT03454568 is a clinical study titled "The Patients' Experience After Stem Cell Transplant". This study will examine how adults ≥ 60 years old thinking and memory abilities are affected by stem cell transplant; whether these changes affect day-to-day activities and quality of life and how thinking and memory abilities are affected by genetics, depression, anxiety and physical function. Gene...
What is the current status of trial NCT03454568?
This trial is currently completed. The enrollment target is 110 participants. The study started on 2017-09-01. Estimated completion is 2022-11-11.
Who is sponsoring clinical trial NCT03454568?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI